13th Annual Meakins-Christie
International Workshop
Le Chateau Bromont
RECENT ADVANCES IN
ALLERGY AND ASTHMA
February 7-8, 2010
Host: Dr. Qutayba Hamid
Coordinator: Maria Makroyanni
Chateau Bromont
90, rue Stanstead
Bromont, QC
Tel: 450-534-4545
GUEST SPEAKERS
Dr. Bruce S. Bochner
Johns Hopkins University, USA
Dr. Redwan Moqbel
University of Manitoba, CANADA
Dr. Maziar Divangahi
McGill University, CANADA
Dr. Parameswaran Nair
McMaster University, CANADA
Dr. Andrew J. Halayko
University of Manitoba, CANADA
Dr. Marc Peters-Golden
University of Michigan, USA
Dr. James C. Hogg
University of British Columbia, CANADA
Dr. Giovanni Piedimonte
West Virginia University, USA
Dr. Nizar N. Jarjour
University of Wisconsin, USA
Dr. David Proud
University of Calgary, CANADA
Dr. Darryl A. Knight
University of British Columbia, CANADA
Dr. Marc E. Rothenberg
University of Cincinnati, USA
Dr. Monica Kraft
Duke University, USA
Dr. Simon Rousseau
McGill University, CANADA
Dr. Mark Larche
McMaster University, CANADA
Dr. Robert P. Schleimer
Northwestern University, USA
Dr. James J. Lee
Mayo Clinic, USA
Dr. Martin Stämpfli
McMaster University, CANADA
Dr. Nick Z. Lu
Johns Hopkins University, USA
Dr. Donata Vercelli
University of Arizona, USA
Dr. Christine McCusker
McGill University, CANADA
Dr. Marsha Wills-Karp
University of Cincinnati, USA
Dr. Zhou Zhu
Johns Hopkins University, USA
SUNDAY, February 7, 2010
7:00
BREAKFAST
8:00
Welcome/Opening Remarks
Dr. Qutayba Hamid
8:15
Studies of inflammation and immunity in the upper airways
of patients with chronic rhinosinusitis
Dr. Robert P. Schleimer
8:45
Epigenetic regulation of epithelial function in asthma:
modifications at the surface or is it a core problem?
Dr. Darryl A. Knight
9:15
Virus-epithelium interactions in the airways: RSV vs
rhinovirus
Dr. Giovanni Piedimonte
9:45
Cigarette smoke extract alters epithelial responses to
rhinovirus infection
Dr. David Proud
10:15
COFFEE BREAK
10:30
Cross-talk between innate and adaptive immunity to
infection
Dr. Maziar Divangahi
11:00
Consequences of heterologous exposure to lung
inflammatory processes elicited by environmental agents in
mice
Dr. Martin Stämpfli
11:30
Remodeling of the terminal bronchiales in COPD: a new
paradigm based on HRCT and micro-CT
Dr. James C. Hogg
SUNDAY, February 7, 2010
12:00
Airway remodeling in asthma: modulation by IL-13
Dr. Monica Kraft
12:30
Initiating airway remodeling by allergen
bronchoprovocation
Dr. Nizar N. Jarjour
1:00
LUNCH
4:00
Eosinophil activities in the lung: you never know where
your next idea will come from or how far it will take you!
Dr. James J. Lee
4:30
Update on the biology of and ligand for eosinophilexpressed Siglec-8 and Siglec F
Dr. Bruce S. Bochner
5:00
Respiratory/esophageal eosinophil axis
Dr. Marc E. Rothenberg
5:30
Eosinophils, IDO and tryptophan catabolites in infant
human thymus
Dr. Redwan Moqbel
6:00
SUPERBOWL DINNER
MONDAY February 8, 2010
7:00
BREAKFAST
8:00
Knocking your SOCS off: silencing of SOCS1 by
leukotriene B4 is required for optimal macrophage myD88
expression and NFkB activation
Dr. Marc Peters-Golden
8:30
Complement regulations of the IL-23
Dr. Marsha Wills-Karp
9:00
Regulation of allergic responses–from men to mice and
back
Dr. Donata Vercelli
9:30
Association of the S100A8/A9-RAGE axis with airway
inflammation, hyperresponsiveness and remodeling
Dr. Andrew J. Halayko
10:00
IL-17 promotes p38MAPK-dependent endothelial activation
enhancing neutrophil recruitment in vivo
Dr. Simon Rousseau
10:30
COFFEE BREAK
10:45
Peptide immunotherapy for the treatment of allergic
asthma: immune mechanisms and prospects for the future
Dr. Mark Larché
11:15
Teaching tolerance: neonatal immuno-education prevents
experimental asthma
Dr. Christine McCusker
11:45
Neutrophils in asthma: friends or foe?
Dr. Parameswaran Nair
MONDAY February 8, 2010
12:15
Tyrosine-phosphatase SHP-1 in mast cell function,
immunological homeostasis and allergic and anaphylactic
responses
Dr. Zhou Zhu
12:45
Glucocorticoid receptor translational isoforms and
glucocorticoid sensitivity
Dr. Nick Z. Lu
1:15
LUNCH
2:30
DEPARTURES
Organized by the
Meakins-Christie Laboratories
of the McGill University Health Centre –
Research Institute
We gratefully acknowledge the generous support of:
MUHC RI
GlaxoSmithKline Canada
Merck Frosst Canada
AstraZeneca Canada
Graceway Canada
CSL Behring
Nycomed Canada